Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Free Cash Flow (2020 - 2026)

Nuvalent's (NUVL) quarterly Free Cash Flow came in at -$92.4 million in Q1 2026, down 68.55% YoY from -$293.8 million in Q1 2025, and down 26.01% on a QoQ basis from -$73.3 million in Q4 2025.

Analysis

Nuvalent (NUVL) Free Cash Flow (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Free Cash Flow data on file, last reported at -$92.4 million in Q1 2026.

  • Quarterly Free Cash Flow fell 68.55% year-over-year to -$92.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$312.8 million (down 53.48% YoY) and the FY2025 annual result came in at -$275.2 million, down 48.71% from the prior year.
  • Free Cash Flow declined to -$92.4 million in Q1 2026, from -$73.3 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$13.5 million in Q1 2022 to a low of -$92.4 million in Q1 2026.
  • A 5-year average of -$42.2 million and a median of -$36.1 million in 2024 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2022 — Free Cash Flow sank 128.25% — and 2025, when it retreated 18.27%.
  • Tracing NUVL's Free Cash Flow over 5 years: stood at -$17.8 million in 2022, then plunged by 69.91% to -$30.2 million in 2023, then plunged by 105.24% to -$62.0 million in 2024, then dropped by 18.27% to -$73.3 million in 2025, then slipped by 26.01% to -$92.4 million in 2026.
  • The last three Free Cash Flow figures came in at -$92.4 million (Q1 2026), -$73.3 million (Q4 2025), and -$70.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - -92.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -92.40 Mn
Dec 31, 2025 -73.33 Mn
Sep 30, 2025 -70.46 Mn
Jun 30, 2025 -76.60 Mn
Mar 31, 2025 -54.82 Mn
Dec 31, 2024 -62.00 Mn
Sep 30, 2024 -45.82 Mn
Jun 30, 2024 -41.16 Mn
Mar 31, 2024 -36.09 Mn
Dec 31, 2023 -30.21 Mn
Sep 30, 2023 -22.98 Mn
Jun 30, 2023 -22.14 Mn
Mar 31, 2023 -24.41 Mn
Dec 31, 2022 -17.78 Mn
Sep 30, 2022 -18.18 Mn
Jun 30, 2022 -15.48 Mn
Mar 31, 2022 -13.54 Mn
Dec 31, 2021 -12.96 Mn
Sep 30, 2021 -11.40 Mn
Jun 30, 2021 -9.71 Mn